ストックスクリーナーアプリを入手
2.66
4.72%
0.12
アフターアワーズ：
2.66
前日終値:
$2.54
開ける：
$2.54
24時間の取引高:
545.39K
Relative Volume:
1.35
時価総額：
$228.76M
収益：
$25.14M
当期純損益:
$-21.57M
株価収益率:
-9.8519
EPS:
-0.27
ネットキャッシュフロー:
$-12.23M
1週間 パフォーマンス:
+18.75%
1か月 パフォーマンス:
+18.22%
6か月 パフォーマンス:
+23.72%
1年 パフォーマンス:
+47.78%
1日の値動き範囲:
$2.54
$2.68
1週間の範囲:
$2.18
$2.68
52週間の値動き範囲:
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
名前
Stereotaxis Inc
セクター
電話
314-678-6100
住所
4320 Forest Park Avenue, Suite 100, St. Louis, MO
STXS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.66 | 225.63M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
478.42 | 168.51B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.96 | 55.46B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.03 | 42.41B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
283.29 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.90 | 17.33B | 2.90B | 467.20M | 306.90M | 6.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-10 | 開始されました | ROTH MKM | Buy |
| 2022-07-12 | 開始されました | Aegis Capital | Buy |
| 2022-06-23 | 開始されました | B. Riley Securities | Buy |
| 2022-01-05 | 開始されました | Craig Hallum | Buy |
| 2022-01-05 | 開始されました | Loop Capital | Buy |
| 2021-05-26 | 開始されました | Piper Sandler | Overweight |
| 2020-09-08 | 開始されました | Northland Capital | Outperform |
| 2020-04-09 | 開始されました | Cowen | Outperform |
| 2020-04-07 | 開始されました | Lake Street | Buy |
すべてを表示
Stereotaxis Inc (STXS) 最新ニュース
Stereotaxis, Inc. (AMEX:STXS) Q2 2025 Earnings Call Transcript - Insider Monkey
Stereotaxis: Pioneering the Future of Robotic Cardiology Amid Strategic Momentum - AInvest
Is Stereotaxis Inc. stock a hidden gemWealth Funnel Stock Screener - newsyoung.net
Does Stereotaxis Inc. show high probability of reboundFree Weekly Watchlist of High Movers - Newser
Stereotaxis reiterates double-digit revenue growth outlook for 2025 as new catheter launches drive commercial momentum - MSN
Forecasting Stereotaxis Inc. price range with options dataFree Day Trading Signals With High Precision - Newser
Intraday pattern recognizer results for Stereotaxis Inc.Strong Buy Signal Summary with Entry Zone - Newser
Historical volatility pattern of Stereotaxis Inc. visualizedFree Daily Smart Money Movement Monitor - Newser
Regression analysis insights on Stereotaxis Inc. performanceFree Triple Digit Growth Focused Trade Plan - Newser
What makes Stereotaxis Inc. stock price move sharplyBuy and Hold Position Summary Review - Newser
Should I buy Stereotaxis Inc. stock before earningsFree Weekly Setup With 3x Return Potential - Newser
Stereotaxis Reports Double-Digit Revenue Growth for 2025 Amidst New Catheter Launches - AInvest
Stereotaxis (STXS): A Robotics-Driven Inflection Point in 2025 - AInvest
Is Stereotaxis Inc. a Top Dividend Stock to Watch in 2025Buy Candidate Summary Based on Fundamentals - Newser
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Stereotaxis Q2 2025 revenue beats forecasts - Investing.com
Best data tools to analyze Stereotaxis Inc. stockFree Weekly Hot Picks With Buy Confidence - Newser
Stereotaxis Inc. recovery potential after sell offLow Risk Trade Timing with Analysis Metrics - Newser
Stereotaxis Q2 2025 Earnings: Revenue Surges to $8.8 Million, EPS of -$0.05 Beats Estimates. - AInvest
Stereotaxis Inc (STXS) Q2 2025 Earnings Call Highlights: Impressive Revenue Surge and Strategic Advancements - GuruFocus
Stereotaxis reports Q2 EPS (5c), consensus (6c) - TipRanks
Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Stereotaxis earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Unlocking Value in Stereotaxis: A High-Growth Medical Tech Play in a Resilient Sector - AInvest
Stereotaxis Reports 2025 Second Quarter Financial Results - GlobeNewswire
Stereotaxis Reports Massive 95% Revenue Jump as New FDA-Cleared Robotic Catheter Drives Growth - Stock Titan
Will Stereotaxis Inc. see short term momentumAI Generated Momentum Stock Forecast Guide - Newser
Does Stereotaxis Inc. stock perform well during market downturnsUnbelievable profit margins - Jammu Links News
What drives Stereotaxis Inc. stock pricePhenomenal returns - Jammu Links News
How strong is Stereotaxis Inc. company’s balance sheetAccelerated investment success - Jammu Links News
What are analysts’ price targets for Stereotaxis Inc. in the next 12 monthsUnprecedented profit potential - Jammu Links News
Should I hold or sell Stereotaxis Inc. stock in 2025Maximize returns with disciplined trading - Jammu Links News
How does Stereotaxis Inc. compare to its industry peersInvest confidently with proven investment plans - Jammu Links News
Stereotaxis Inc. Stock Analysis and ForecastDynamic profit expansion - Jammu Links News
What is Stereotaxis Inc. company’s growth strategyRapidly growing investment returns - Jammu Links News
Is Stereotaxis Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
What institutional investors are buying Stereotaxis Inc. stockFree Buy/Sell Signal Notifications - Jammu Links News
Trendlines Suggest Stereotaxis Inc. May Bottom Out SoonAccurate Buy Point for Momentum Stocks Detected - metal.it
Stereotaxis Inc.’s volatility index tracking explainedFree Reliable Alerts for Daily Stock Movers - Newser
What are Stereotaxis Inc. company’s key revenue driversAI Powered Growth Plan For 2025 - Jammu Links News
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared - MedTech Dive
Stereotaxis Inc. Q2 Earnings Preview: Revenue Up 76.7%, EPS Unchanged - AInvest
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Is Stereotaxis Inc. stock bottoming outReliable Alerts for Daily Stock Movers Released - metal.it
Why did STXS revenue surge in Q3 2024 despite rising expenses? - AInvest
How does Stereotaxis Inc. generate profit in a changing economySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Navigating STXS’s Stock Market Maze: Ups and Downs in 2025 - investchronicle.com
Stereotaxis' MAGiC Sweep: A Strategic Inflection Point in Robotic Electrophysiology - AInvest
Stereotaxis wins FDA clearance for diagnostic mapping catheter - Yahoo Finance
Stereotaxis' FDA-Cleared MAGiC Sweep Catheter: A Catalyst for Growth in the Robotic Ablation Era - AInvest
Stereotaxis Wins FDA Nod for MAGiC Sweep EP Catheter - Medical Product Outsourcing
Stereotaxis Inc (STXS) 財務データ
収益
当期純利益
現金流量
EPS
4.21%
0.06%
大文字化:
|
ボリューム (24 時間):